Filter
1454
Filtered Results: 1454
Text search:
N.
Ford
Featured
Recommendations
125
New Publications
168
Language
Document type
Studies & Reports
500
No document type
379
Guidelines
317
Manuals
120
Strategic & Response Plan
71
Training Material
26
Fact sheets
24
Situation Updates
6
Resource Platforms
5
Brochures
4
Infographics
2
Countries / Regions
Global
92
India
65
Germany
56
South Africa
37
Africa
33
Kenya
32
Latin America and the Carribbean
28
Western and Central Europe
28
Ukraine
22
Malawi
18
Nigeria
17
West and Central Africa
14
Brazil
14
Russia
14
Middle East and North Africa
12
Ethiopia
12
East and Southern Africa
11
Syria
10
Senegal
10
Philippines
10
Bangladesh
10
South Sudan
10
Nepal
9
Colombia
9
Uganda
9
Ghana
8
Sierra Leone
8
Congo, Democratic Republic of
8
Eastern Europe and Central Asia
8
Eastern Europe
8
Thailand
7
South–East Asia Region
7
Myanmar / Burma
7
Rwanda
6
Burkina Faso
6
Mozambique
6
Cambodia
6
Tanzania
6
Indonesia
6
Liberia
6
USA
5
Zambia
5
Lesotho
4
Cameroon
4
Kyrgyzstan
4
Peru
4
Guinea
4
North America
4
Argentina
4
Sudan
4
Eswatini/ Swaziland
4
Switzerland
3
Benin
3
Haiti
3
Asia
3
Jamaica
3
Vietnam
3
Moldova
3
Yemen
3
Botswana
3
Pakistan
3
North Macedonia
2
Timor Leste/ East Timor
2
Mexico
2
China
2
Kazakhstan
2
Chile
2
Estonia
2
Afghanistan
2
Zimbabwe
2
Venezuela
2
Hungary
2
Western Pacific Region
2
Portugal
2
Azerbaijan
2
Southern Africa
2
Lebanon
2
Romania
2
Georgia
2
Poland
2
Tajikistan
1
Serbia
1
Iran
1
Laos
1
Congo-Brazzaville
1
Burundi
1
Austria
1
Morocco
1
Mongolia
1
Italy
1
Guinea-Bissau
1
Croatia
1
Jordan
1
Turkmenistan
1
Japan
1
Norway
1
Spain
1
Belarus
1
Bosnia and Herzegovina
1
Côte d’Ivoire / Ivory Coast
1
Sri Lanka
1
Central African Republic
1
Mali
1
Angola
1
Libya
1
Iraq
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
417
Clinical Guidelines
133
Public Health
91
Women & Child Health
57
Key Resources
55
Pharmacy & Technologies
23
Capacity Building
14
Toolboxes
COVID-19
191
HIV
128
Planetary Health
107
Mental Health
96
Caregiver
79
AMR
78
Refugee
72
NTDs
71
TB
62
NCDs
53
Conflict
40
Pharmacy
36
Rapid Response
35
Global Health Education
33
Disability
31
Health Financing Toolbox
28
Natural Hazards
17
Ebola
15
Social Ethics
12
Specific Hazards
8
Cholera
8
Polio
6
Zika
3
Health Financing
2
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
Herausforderungen und Handlungsempfehlungen
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
Women have less access to the development services and support – such as adequate healthcare, education and
modern technology – that make people more resilient to climate change and other shocks and stressors.2
Women’s unequal access to resources, their disproportionate responsibility for ca...
EBRD expects Ukraine’s economy to contract by nearly a third in 2022
- EBRD continues to expect Ukraine’s economy to shrink by 30 per cent in 2022
- Bank lowers 2023 GDP growth forecast from 25 per cent to 8 per cent
- EBRD Regional Economic Prospects (REP) report highlights war-induced uncer...
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
This Trachoma Action Planning – a planning guide – is published by the
International Coalition for Trachoma Control at the request of the
World Health Organization Alliance for the Global Elimination of Trachoma
by 2020.
This new guidance aims to support programme implementers, coordinators and others in humanitarian settings in their actions to counter suicide and self-harm in humanitarian contexts and to save lives.
In 2011, ICTC developed a Trachoma Action Plan (TAP) planning guide to support national health officials in endemic countries. This resource was developed to complement the 2020 INSight roadmap by helping countries create specific national plans detailing how they will reach elimination targets in t...
The Indigenous tribe called the Wiwa lives retracted in the Sierra Nevada de Santa Marta, Colombia. Little is known about their health status and whether the health care system in place covers their needs.
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
A key component of elimination is to reduce the number
of unmanaged trachomatous trichiasis cases to less than
1 per 1,000 population in affected areas. This will require
not only a large increase in the number of surgeries
performed, but also improvements in the quality of surgery
and in the e...
This strategy defines the World Health Organization (WHO) vision and framework for supporting Member States to accelerate the development, implementation and monitoring of their National Action Plan for Health Security (NAPHS) from 2022 to 2026. The National Action Plan for Health Security (NAPHS) ...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
